©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 14, 2025; 31(18): 105866
Published online May 14, 2025. doi: 10.3748/wjg.v31.i18.105866
Published online May 14, 2025. doi: 10.3748/wjg.v31.i18.105866
Importance of understanding a diagnostic-treatment algorithm for primary hyperparathyroidism-induced acute pancreatitis during pregnancy
Kenya Kamimura, Department of General Medicine, Niigata University, Niigata 9518510, Japan
Kenya Kamimura, Shuji Terai, Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 9518510, Japan
Author contributions: Kamimura K and Terai S contributed to the data analyses, manuscript drafting, and writing.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Kenya Kamimura, MD, PhD, Professor, Department of General Medicine, Niigata University, 1-757 Asahimachi do-ri, Niigata 9518510, Japan.
Received: February 10, 2025
Revised: March 12, 2025
Accepted: March 26, 2025
Published online: May 14, 2025
Processing time: 94 Days and 1.3 Hours
Revised: March 12, 2025
Accepted: March 26, 2025
Published online: May 14, 2025
Processing time: 94 Days and 1.3 Hours
Core Tip
Core Tip: Primary hyperparathyroidism-induced acute pancreatitis during pregnancy is a rare condition and can cause maternal and fetal adverse outcomes. Therefore, early diagnosis and appropriate therapeutic intervention are essential. This article comments on the recent systematic review of this condition published in the World Journal of Gastroenterology. In addition, multiple endocrine neoplasia screening is recommended for the better prognosis of the cases.